Morishita Jintan Co., Ltd. (4524.T)

JPY 2065.0

(-0.24%)

Total Liabilities Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual total liabilities in 2023 was 5.04 Billion JPY , up 6.96% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly total liabilities in 2024 Q1 was 5.49 Billion JPY , up 9.03% from previous quarter.
  • Morishita Jintan Co., Ltd. reported annual total liabilities of 4.71 Billion JPY in 2022, up 17.07% from previous year.
  • Morishita Jintan Co., Ltd. reported annual total liabilities of 4.02 Billion JPY in 2021, down -3.57% from previous year.
  • Morishita Jintan Co., Ltd. reported quarterly total liabilities of 5.05 Billion JPY for 2023 Q2, up 2.35% from previous quarter.
  • Morishita Jintan Co., Ltd. reported quarterly total liabilities of 5.04 Billion JPY for 2023 Q4, down -2.1% from previous quarter.

Annual Total Liabilities Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Total Liabilities of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 5.04 Billion JPY 6.96%
2022 4.71 Billion JPY 17.07%
2021 4.02 Billion JPY -3.57%
2020 4.17 Billion JPY -4.53%
2019 4.37 Billion JPY 0.0%

Peer Total Liabilities Comparison of Morishita Jintan Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Pharma Foods International Co., Ltd. 24.98 Billion JPY 79.83%
Takeda Pharmaceutical Company Limited 7834.78 Billion JPY 99.936%
Sumitomo Pharma Co., Ltd. 751.37 Billion JPY 99.329%
Shionogi & Co., Ltd. 164.35 Billion JPY 96.933%
Wakamoto Pharmaceutical Co.,Ltd. 3.39 Billion JPY -48.455%
Nippon Shinyaku Co., Ltd. 42.86 Billion JPY 88.243%
Kaken Pharmaceutical Co., Ltd. 27.86 Billion JPY 81.913%
Eisai Co., Ltd. 494.82 Billion JPY 98.981%
Hisamitsu Pharmaceutical Co., Inc. 61.69 Billion JPY 91.831%
Mochida Pharmaceutical Co., Ltd. 30.83 Billion JPY 83.653%
Fuso Pharmaceutical Industries,Ltd. 39.79 Billion JPY 87.335%
Nippon Chemiphar Co., Ltd. 31.08 Billion JPY 83.786%
Tsumura & Co. 132.88 Billion JPY 96.207%
Kissei Pharmaceutical Co., Ltd. 39.79 Billion JPY 87.334%
Torii Pharmaceutical Co., Ltd. 13.29 Billion JPY 62.097%
Towa Pharmaceutical Co., Ltd. 274.75 Billion JPY 98.166%
Fuji Pharma Co., Ltd. 44.15 Billion JPY 88.586%
Zeria Pharmaceutical Co., Ltd. 70.7 Billion JPY 92.872%
KYORIN Holdings, Inc. 46.89 Billion JPY 89.252%
Taiko Pharmaceutical Co.,Ltd. 7 Billion JPY 28.031%
Daito Pharmaceutical Co.,Ltd. 25.43 Billion JPY 80.188%
SymBio Pharmaceuticals Limited 8.14 Billion JPY 38.1%
MedRx Co., Ltd 129 Million JPY -3806.977%
Mizuho Medy Co.,Ltd. 3.27 Billion JPY -54.009%
Solasia Pharma K.K. 673 Million JPY -648.886%
Modalis Therapeutics Corporation 645.5 Million JPY -680.786%
ASKA Pharmaceutical Holdings Co.,Ltd. 31.38 Billion JPY 83.939%
Sawai Group Holdings Co., Ltd. 163.99 Billion JPY 96.927%
Cyfuse Biomedical K.K. 1.01 Billion JPY -398.349%
Toho Holdings Co., Ltd. 523.98 Billion JPY 99.038%
Koa Shoji Holdings Co.,Ltd. 6.95 Billion JPY 27.506%